Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 7 | -$0.77 | -$0.61 | -$0.72 |
| Q2 2026 | 7 | -$0.83 | -$0.67 | -$0.76 |
| Q3 2026 | 3 | -$0.76 | -$0.76 | -$0.76 |
| Q4 2026 | 3 | -$0.80 | -$0.80 | -$0.80 |
| Q1 2027 | 3 | -$0.76 | -$0.76 | -$0.76 |
| Q2 2027 | 2 | -$0.76 | -$0.76 | -$0.76 |
| Q3 2027 | 2 | -$0.74 | -$0.74 | -$0.74 |
| Q4 2027 | 2 | -$0.62 | -$0.62 | -$0.62 |
Pharvaris NV last posted its earnings results on Thursday, April 2nd, 2026. The company reported $-0.84565 earnings per share for the quarter, missing analysts' consensus estimates of $-0.71462 by $0.13103. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Pharvaris NV has generated $-3 earnings per share over the last year ($-2.97 diluted earnings per share) and currently has a price-to-earnings ratio of -8.62. Pharvaris NV has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/02/2026 | Q4 2025 | -$0.71 | -$0.79 | -0.08 | $0 | $0 |
| 11/12/2025 | Q3 2025 | -$0.78 | -$0.60 | 0.18 | N/A | $0 |
| 08/12/2025 | Q2 2025 | -$0.87 | -$0.83 | 0.04 | N/A | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$0.85 | N/A | N/A | $0 |
| 04/07/2025 | Q4 2024 | N/A | -$0.64 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.77 | N/A | N/A | $0 |
| 06/28/2024 | Q2 2024 | N/A | -$0.55 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.52 | N/A | N/A | $0 |
| 04/10/2024 | Q4 2023 | N/A | -$0.61 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.58 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | $0.02 | N/A | N/A | $0 |
| 04/05/2023 | Q1 2023 | N/A | -$0.67 | N/A | N/A | $0 |
| 04/05/2023 | Q4 2022 | N/A | -$1.16 | N/A | N/A | $0 |
| 09/30/2022 | Q3 2022 | N/A | -$0.25 | N/A | N/A | $0 |
| 07/01/2022 | Q2 2022 | N/A | -$0.38 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.48 | N/A | N/A | $0 |
| 03/29/2022 | Q4 2021 | -$0.74 | -$0.37 | 0.37 | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.28 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.46 | N/A | N/A | $0 |
| 04/30/2021 | Q1 2021 | N/A | -$0.19 | N/A | N/A | $0 |
The conference call for Pharvaris NV's latest earnings report can be listened to online.
The conference call transcript for Pharvaris NV's latest earnings report can be read online.
Pharvaris NV (:PHVS) has a recorded net income of $-175,699,397.Pharvaris NV has generated $-2.97 earnings per share over the last four quarters.
Pharvaris NV (:PHVS) has a price-to-earnings ratio of -8.62 and price/earnings-to-growth ratio is 0.39.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED